Functional activity of CXCL8 receptors, CXCR1 and CXCR2, on human malignant melanoma progression
Abstract We examined the autocrine/paracrine role of interleukin-8 (CXCL8) and the functional significance of CXCL8 receptors, CXCR1 and CXCR2, in human malignant melanoma proliferation, migration, invasion and angiogenesis. We found that a panel of seven cell lines, even though at different extent,...
Gespeichert in:
Veröffentlicht in: | European journal of cancer (1990) 2009-09, Vol.45 (14), p.2618-2627 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 2627 |
---|---|
container_issue | 14 |
container_start_page | 2618 |
container_title | European journal of cancer (1990) |
container_volume | 45 |
creator | Gabellini, Chiara Trisciuoglio, Daniela Desideri, Marianna Candiloro, Antonio Ragazzoni, Ylenia Orlandi, Augusto Zupi, Gabriella Del Bufalo, Donatella |
description | Abstract We examined the autocrine/paracrine role of interleukin-8 (CXCL8) and the functional significance of CXCL8 receptors, CXCR1 and CXCR2, in human malignant melanoma proliferation, migration, invasion and angiogenesis. We found that a panel of seven cell lines, even though at different extent, secreted CXCL8 protein, and expressed CXCR1 and CXCR2 independently from the CXCL8 expression, but depending on the oxygen level. In fact, hypoxic exposure increases the expression of CXCR1 and CXCR2. The cell proliferation of both M20 and A375SM lines, expressing similar levels of both CXCR1 and CXCR2 but secreting low and high amounts of CXCL8, respectively, was significantly enhanced by CXCL8 exposure and reduced by CXCL8, CXCR1 and CXCR2 neutralising antibodies, indicating the autocrine/paracrine role of CXCL8 in melanoma cell proliferation. Moreover, an increased invasion and migration in response to CXCL8 was observed in several cell lines, and a further enhancement evidenced under hypoxic conditions. A CXCL8-dependent in vivo vessel formation, evaluated through a matrigel assay, was also demonstrated. Furthermore, when neutralising antibodies against CXCR1 or CXCR2 were used, only the involvement of CXCR2, but not CXCR1 was observed on cell migration and invasion, while both receptors played a role in angiogenesis. In summary, our data demonstrate that CXCL8 induces cell proliferation and angiogenesis through both receptors and that CXCR2 plays an important role in regulating the CXCL8-mediated invasive and migratory behaviour of human melanoma cells. Thus, blocking the CXCL8 signalling axis promises an improvement for the therapy of cancer and, in particular, of metastatic melanoma. |
doi_str_mv | 10.1016/j.ejca.2009.07.007 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67621711</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0959804909005449</els_id><sourcerecordid>21086665</sourcerecordid><originalsourceid>FETCH-LOGICAL-c536t-ff7366a6600d0460acb9efe35f9f175284740518d596846e9e1bd460e7bc0ea23</originalsourceid><addsrcrecordid>eNqFkl2r1DAQhosonvXoH_BCcqNXp3WStvkAEWTxqLAg-AHexWw6Paa2yZq0B_bfm7qLghd6lSE87zvDvFMUjylUFCh_PlQ4WFMxAFWBqADEnWJDpVAlyJbdLTagWlVKaNRF8SClATIhG7hfXFDFZd3UsCm-Xi_ezi54MxKTi1s3H0noyfbLdidJRIuHOcR0tX58oMT47lfFrkjw5NsyGU8mM7obb_xMJhyND5MhhxhuIqaUfR8W93ozJnx0fi-Lz9evP23flrv3b95tX-1K29Z8Lvte1JwbzgE6aDgYu1fYY932qqeiZbIRDbRUdm0eveGokO67zKHYW0DD6svi2ck39_6xYJr15JLFMU-EYUmaC86ooPS_IKMgOedtBtkJtDGkFLHXh-gmE4-agl4D0INeA9BrABqEzuvNoidn92U_YfdHct54Bp6eAZOsGftovHXpN8eoqhXUMnMvThzmpd06jDpZh95i53Iqs-6C-_ccL_-S29F5lzt-xyOmISwxR5401Ylp0B_XU1kvBRRA2zSq_gkY9rbE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>21086665</pqid></control><display><type>article</type><title>Functional activity of CXCL8 receptors, CXCR1 and CXCR2, on human malignant melanoma progression</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Gabellini, Chiara ; Trisciuoglio, Daniela ; Desideri, Marianna ; Candiloro, Antonio ; Ragazzoni, Ylenia ; Orlandi, Augusto ; Zupi, Gabriella ; Del Bufalo, Donatella</creator><creatorcontrib>Gabellini, Chiara ; Trisciuoglio, Daniela ; Desideri, Marianna ; Candiloro, Antonio ; Ragazzoni, Ylenia ; Orlandi, Augusto ; Zupi, Gabriella ; Del Bufalo, Donatella</creatorcontrib><description>Abstract We examined the autocrine/paracrine role of interleukin-8 (CXCL8) and the functional significance of CXCL8 receptors, CXCR1 and CXCR2, in human malignant melanoma proliferation, migration, invasion and angiogenesis. We found that a panel of seven cell lines, even though at different extent, secreted CXCL8 protein, and expressed CXCR1 and CXCR2 independently from the CXCL8 expression, but depending on the oxygen level. In fact, hypoxic exposure increases the expression of CXCR1 and CXCR2. The cell proliferation of both M20 and A375SM lines, expressing similar levels of both CXCR1 and CXCR2 but secreting low and high amounts of CXCL8, respectively, was significantly enhanced by CXCL8 exposure and reduced by CXCL8, CXCR1 and CXCR2 neutralising antibodies, indicating the autocrine/paracrine role of CXCL8 in melanoma cell proliferation. Moreover, an increased invasion and migration in response to CXCL8 was observed in several cell lines, and a further enhancement evidenced under hypoxic conditions. A CXCL8-dependent in vivo vessel formation, evaluated through a matrigel assay, was also demonstrated. Furthermore, when neutralising antibodies against CXCR1 or CXCR2 were used, only the involvement of CXCR2, but not CXCR1 was observed on cell migration and invasion, while both receptors played a role in angiogenesis. In summary, our data demonstrate that CXCL8 induces cell proliferation and angiogenesis through both receptors and that CXCR2 plays an important role in regulating the CXCL8-mediated invasive and migratory behaviour of human melanoma cells. Thus, blocking the CXCL8 signalling axis promises an improvement for the therapy of cancer and, in particular, of metastatic melanoma.</description><identifier>ISSN: 0959-8049</identifier><identifier>EISSN: 1879-0852</identifier><identifier>DOI: 10.1016/j.ejca.2009.07.007</identifier><identifier>PMID: 19683430</identifier><language>eng</language><publisher>Kidlington: Elsevier Ltd</publisher><subject>Animals ; Biological and medical sciences ; Cell hypoxia ; Cell Line, Tumor ; Cell Movement ; Cell Proliferation ; Chemotaxis ; CXCR1 ; CXCR2 ; Hematology, Oncology and Palliative Medicine ; Humans ; Interleukin-8 ; Interleukin-8 - metabolism ; Medical sciences ; Melanoma ; Melanoma - blood supply ; Melanoma - metabolism ; Mice ; Mice, Nude ; Neoplasm Invasiveness ; Neoplasm Proteins - metabolism ; Neovascularization, Pathologic - etiology ; Pathologic neovascularisation ; Pharmacology. Drug treatments ; Receptors, Interleukin-8A - metabolism ; Receptors, Interleukin-8B - metabolism ; Tumors</subject><ispartof>European journal of cancer (1990), 2009-09, Vol.45 (14), p.2618-2627</ispartof><rights>Elsevier Ltd</rights><rights>2009 Elsevier Ltd</rights><rights>2009 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c536t-ff7366a6600d0460acb9efe35f9f175284740518d596846e9e1bd460e7bc0ea23</citedby><cites>FETCH-LOGICAL-c536t-ff7366a6600d0460acb9efe35f9f175284740518d596846e9e1bd460e7bc0ea23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.ejca.2009.07.007$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=21939038$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19683430$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gabellini, Chiara</creatorcontrib><creatorcontrib>Trisciuoglio, Daniela</creatorcontrib><creatorcontrib>Desideri, Marianna</creatorcontrib><creatorcontrib>Candiloro, Antonio</creatorcontrib><creatorcontrib>Ragazzoni, Ylenia</creatorcontrib><creatorcontrib>Orlandi, Augusto</creatorcontrib><creatorcontrib>Zupi, Gabriella</creatorcontrib><creatorcontrib>Del Bufalo, Donatella</creatorcontrib><title>Functional activity of CXCL8 receptors, CXCR1 and CXCR2, on human malignant melanoma progression</title><title>European journal of cancer (1990)</title><addtitle>Eur J Cancer</addtitle><description>Abstract We examined the autocrine/paracrine role of interleukin-8 (CXCL8) and the functional significance of CXCL8 receptors, CXCR1 and CXCR2, in human malignant melanoma proliferation, migration, invasion and angiogenesis. We found that a panel of seven cell lines, even though at different extent, secreted CXCL8 protein, and expressed CXCR1 and CXCR2 independently from the CXCL8 expression, but depending on the oxygen level. In fact, hypoxic exposure increases the expression of CXCR1 and CXCR2. The cell proliferation of both M20 and A375SM lines, expressing similar levels of both CXCR1 and CXCR2 but secreting low and high amounts of CXCL8, respectively, was significantly enhanced by CXCL8 exposure and reduced by CXCL8, CXCR1 and CXCR2 neutralising antibodies, indicating the autocrine/paracrine role of CXCL8 in melanoma cell proliferation. Moreover, an increased invasion and migration in response to CXCL8 was observed in several cell lines, and a further enhancement evidenced under hypoxic conditions. A CXCL8-dependent in vivo vessel formation, evaluated through a matrigel assay, was also demonstrated. Furthermore, when neutralising antibodies against CXCR1 or CXCR2 were used, only the involvement of CXCR2, but not CXCR1 was observed on cell migration and invasion, while both receptors played a role in angiogenesis. In summary, our data demonstrate that CXCL8 induces cell proliferation and angiogenesis through both receptors and that CXCR2 plays an important role in regulating the CXCL8-mediated invasive and migratory behaviour of human melanoma cells. Thus, blocking the CXCL8 signalling axis promises an improvement for the therapy of cancer and, in particular, of metastatic melanoma.</description><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Cell hypoxia</subject><subject>Cell Line, Tumor</subject><subject>Cell Movement</subject><subject>Cell Proliferation</subject><subject>Chemotaxis</subject><subject>CXCR1</subject><subject>CXCR2</subject><subject>Hematology, Oncology and Palliative Medicine</subject><subject>Humans</subject><subject>Interleukin-8</subject><subject>Interleukin-8 - metabolism</subject><subject>Medical sciences</subject><subject>Melanoma</subject><subject>Melanoma - blood supply</subject><subject>Melanoma - metabolism</subject><subject>Mice</subject><subject>Mice, Nude</subject><subject>Neoplasm Invasiveness</subject><subject>Neoplasm Proteins - metabolism</subject><subject>Neovascularization, Pathologic - etiology</subject><subject>Pathologic neovascularisation</subject><subject>Pharmacology. Drug treatments</subject><subject>Receptors, Interleukin-8A - metabolism</subject><subject>Receptors, Interleukin-8B - metabolism</subject><subject>Tumors</subject><issn>0959-8049</issn><issn>1879-0852</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkl2r1DAQhosonvXoH_BCcqNXp3WStvkAEWTxqLAg-AHexWw6Paa2yZq0B_bfm7qLghd6lSE87zvDvFMUjylUFCh_PlQ4WFMxAFWBqADEnWJDpVAlyJbdLTagWlVKaNRF8SClATIhG7hfXFDFZd3UsCm-Xi_ezi54MxKTi1s3H0noyfbLdidJRIuHOcR0tX58oMT47lfFrkjw5NsyGU8mM7obb_xMJhyND5MhhxhuIqaUfR8W93ozJnx0fi-Lz9evP23flrv3b95tX-1K29Z8Lvte1JwbzgE6aDgYu1fYY932qqeiZbIRDbRUdm0eveGokO67zKHYW0DD6svi2ck39_6xYJr15JLFMU-EYUmaC86ooPS_IKMgOedtBtkJtDGkFLHXh-gmE4-agl4D0INeA9BrABqEzuvNoidn92U_YfdHct54Bp6eAZOsGftovHXpN8eoqhXUMnMvThzmpd06jDpZh95i53Iqs-6C-_ccL_-S29F5lzt-xyOmISwxR5401Ylp0B_XU1kvBRRA2zSq_gkY9rbE</recordid><startdate>20090901</startdate><enddate>20090901</enddate><creator>Gabellini, Chiara</creator><creator>Trisciuoglio, Daniela</creator><creator>Desideri, Marianna</creator><creator>Candiloro, Antonio</creator><creator>Ragazzoni, Ylenia</creator><creator>Orlandi, Augusto</creator><creator>Zupi, Gabriella</creator><creator>Del Bufalo, Donatella</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>20090901</creationdate><title>Functional activity of CXCL8 receptors, CXCR1 and CXCR2, on human malignant melanoma progression</title><author>Gabellini, Chiara ; Trisciuoglio, Daniela ; Desideri, Marianna ; Candiloro, Antonio ; Ragazzoni, Ylenia ; Orlandi, Augusto ; Zupi, Gabriella ; Del Bufalo, Donatella</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c536t-ff7366a6600d0460acb9efe35f9f175284740518d596846e9e1bd460e7bc0ea23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Cell hypoxia</topic><topic>Cell Line, Tumor</topic><topic>Cell Movement</topic><topic>Cell Proliferation</topic><topic>Chemotaxis</topic><topic>CXCR1</topic><topic>CXCR2</topic><topic>Hematology, Oncology and Palliative Medicine</topic><topic>Humans</topic><topic>Interleukin-8</topic><topic>Interleukin-8 - metabolism</topic><topic>Medical sciences</topic><topic>Melanoma</topic><topic>Melanoma - blood supply</topic><topic>Melanoma - metabolism</topic><topic>Mice</topic><topic>Mice, Nude</topic><topic>Neoplasm Invasiveness</topic><topic>Neoplasm Proteins - metabolism</topic><topic>Neovascularization, Pathologic - etiology</topic><topic>Pathologic neovascularisation</topic><topic>Pharmacology. Drug treatments</topic><topic>Receptors, Interleukin-8A - metabolism</topic><topic>Receptors, Interleukin-8B - metabolism</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gabellini, Chiara</creatorcontrib><creatorcontrib>Trisciuoglio, Daniela</creatorcontrib><creatorcontrib>Desideri, Marianna</creatorcontrib><creatorcontrib>Candiloro, Antonio</creatorcontrib><creatorcontrib>Ragazzoni, Ylenia</creatorcontrib><creatorcontrib>Orlandi, Augusto</creatorcontrib><creatorcontrib>Zupi, Gabriella</creatorcontrib><creatorcontrib>Del Bufalo, Donatella</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of cancer (1990)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gabellini, Chiara</au><au>Trisciuoglio, Daniela</au><au>Desideri, Marianna</au><au>Candiloro, Antonio</au><au>Ragazzoni, Ylenia</au><au>Orlandi, Augusto</au><au>Zupi, Gabriella</au><au>Del Bufalo, Donatella</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Functional activity of CXCL8 receptors, CXCR1 and CXCR2, on human malignant melanoma progression</atitle><jtitle>European journal of cancer (1990)</jtitle><addtitle>Eur J Cancer</addtitle><date>2009-09-01</date><risdate>2009</risdate><volume>45</volume><issue>14</issue><spage>2618</spage><epage>2627</epage><pages>2618-2627</pages><issn>0959-8049</issn><eissn>1879-0852</eissn><abstract>Abstract We examined the autocrine/paracrine role of interleukin-8 (CXCL8) and the functional significance of CXCL8 receptors, CXCR1 and CXCR2, in human malignant melanoma proliferation, migration, invasion and angiogenesis. We found that a panel of seven cell lines, even though at different extent, secreted CXCL8 protein, and expressed CXCR1 and CXCR2 independently from the CXCL8 expression, but depending on the oxygen level. In fact, hypoxic exposure increases the expression of CXCR1 and CXCR2. The cell proliferation of both M20 and A375SM lines, expressing similar levels of both CXCR1 and CXCR2 but secreting low and high amounts of CXCL8, respectively, was significantly enhanced by CXCL8 exposure and reduced by CXCL8, CXCR1 and CXCR2 neutralising antibodies, indicating the autocrine/paracrine role of CXCL8 in melanoma cell proliferation. Moreover, an increased invasion and migration in response to CXCL8 was observed in several cell lines, and a further enhancement evidenced under hypoxic conditions. A CXCL8-dependent in vivo vessel formation, evaluated through a matrigel assay, was also demonstrated. Furthermore, when neutralising antibodies against CXCR1 or CXCR2 were used, only the involvement of CXCR2, but not CXCR1 was observed on cell migration and invasion, while both receptors played a role in angiogenesis. In summary, our data demonstrate that CXCL8 induces cell proliferation and angiogenesis through both receptors and that CXCR2 plays an important role in regulating the CXCL8-mediated invasive and migratory behaviour of human melanoma cells. Thus, blocking the CXCL8 signalling axis promises an improvement for the therapy of cancer and, in particular, of metastatic melanoma.</abstract><cop>Kidlington</cop><pub>Elsevier Ltd</pub><pmid>19683430</pmid><doi>10.1016/j.ejca.2009.07.007</doi><tpages>10</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0959-8049 |
ispartof | European journal of cancer (1990), 2009-09, Vol.45 (14), p.2618-2627 |
issn | 0959-8049 1879-0852 |
language | eng |
recordid | cdi_proquest_miscellaneous_67621711 |
source | MEDLINE; ScienceDirect Journals (5 years ago - present) |
subjects | Animals Biological and medical sciences Cell hypoxia Cell Line, Tumor Cell Movement Cell Proliferation Chemotaxis CXCR1 CXCR2 Hematology, Oncology and Palliative Medicine Humans Interleukin-8 Interleukin-8 - metabolism Medical sciences Melanoma Melanoma - blood supply Melanoma - metabolism Mice Mice, Nude Neoplasm Invasiveness Neoplasm Proteins - metabolism Neovascularization, Pathologic - etiology Pathologic neovascularisation Pharmacology. Drug treatments Receptors, Interleukin-8A - metabolism Receptors, Interleukin-8B - metabolism Tumors |
title | Functional activity of CXCL8 receptors, CXCR1 and CXCR2, on human malignant melanoma progression |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T11%3A11%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Functional%20activity%20of%20CXCL8%20receptors,%20CXCR1%20and%20CXCR2,%20on%20human%20malignant%20melanoma%20progression&rft.jtitle=European%20journal%20of%20cancer%20(1990)&rft.au=Gabellini,%20Chiara&rft.date=2009-09-01&rft.volume=45&rft.issue=14&rft.spage=2618&rft.epage=2627&rft.pages=2618-2627&rft.issn=0959-8049&rft.eissn=1879-0852&rft_id=info:doi/10.1016/j.ejca.2009.07.007&rft_dat=%3Cproquest_cross%3E21086665%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=21086665&rft_id=info:pmid/19683430&rft_els_id=1_s2_0_S0959804909005449&rfr_iscdi=true |